LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 2 of 15: Cell count and relative growth within biological replicate 2. - Dataset (ID:20238)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SK-BR-3 | XMD11-85h | 0.04 | uM | LJP6 | 2 | P24 | 72 | hr | 2543 | 4127 | 5578 | 0.7398 | 0.5217 |
MCF 10A | Trametinib | 0.04 | uM | LJP5 | 1 | P24 | 72 | hr | 1694 | 2800 | 11155 | 0.2510 | 0.1169 |
MCF 10A | Trametinib | 0.04 | uM | LJP5 | 2 | P24 | 72 | hr | 1694 | 2568 | 11155 | 0.2302 | 0.0923 |
SK-BR-3 | XMD11-85h | 0.04 | uM | LJP6 | 1 | P24 | 72 | hr | 2543 | 4083 | 5578 | 0.7319 | 0.5072 |
MCF7 | XMD11-85h | 0.04 | uM | LJP6 | 1 | P24 | 72 | hr | 1389 | 3116 | 5667 | 0.5498 | 0.4036 |
MDA-MB-231 | XMD11-85h | 0.04 | uM | LJP6 | 1 | P24 | 72 | hr | 1311 | 3724 | 5013 | 0.7428 | 0.6517 |
Hs 578T | Trametinib | 0.04 | uM | LJP5 | 2 | P24 | 72 | hr | 765 | 1218 | 3124 | 0.3898 | 0.1920 |
SK-BR-3 | XMD11-85h | 0.04 | uM | LJP6 | 3 | P24 | 72 | hr | 2543 | 3925 | 5578 | 0.7036 | 0.4552 |
MDA-MB-231 | XMD11-85h | 0.04 | uM | LJP6 | 3 | P24 | 72 | hr | 1311 | 3785 | 5013 | 0.7550 | 0.6681 |
MDA-MB-231 | XMD11-85h | 0.04 | uM | LJP6 | 2 | P24 | 72 | hr | 1311 | 3936 | 5013 | 0.7851 | 0.7089 |
BT-20 | Trametinib | 0.04 | uM | LJP5 | 1 | P24 | 72 | hr | 1334 | 3109 | 3970 | 0.7829 | 0.6731 |
MCF7 | XMD11-85h | 0.04 | uM | LJP6 | 3 | P24 | 72 | hr | 1389 | 4594 | 5667 | 0.8105 | 0.7490 |
MCF 10A | Trametinib | 0.04 | uM | LJP5 | 3 | P24 | 72 | hr | 1694 | 2900 | 11155 | 0.2600 | 0.1274 |
SK-BR-3 | Trametinib | 0.04 | uM | LJP5 | 2 | P24 | 72 | hr | 2543 | 3447 | 5578 | 0.6179 | 0.2977 |
BT-20 | Trametinib | 0.04 | uM | LJP5 | 3 | P24 | 72 | hr | 1334 | 3431 | 3970 | 0.8640 | 0.7952 |
MCF7 | Trametinib | 0.04 | uM | LJP5 | 1 | P24 | 72 | hr | 1389 | 2625 | 5667 | 0.4631 | 0.2889 |
MDA-MB-231 | Trametinib | 0.04 | uM | LJP5 | 1 | P24 | 72 | hr | 1311 | 1530 | 5013 | 0.3052 | 0.0590 |
BT-20 | Trametinib | 0.04 | uM | LJP5 | 2 | P24 | 72 | hr | 1334 | 2925 | 3970 | 0.7366 | 0.6033 |
MDA-MB-231 | Trametinib | 0.04 | uM | LJP5 | 2 | P24 | 72 | hr | 1311 | 1592 | 5013 | 0.3175 | 0.0757 |
MCF7 | Trametinib | 0.04 | uM | LJP5 | 3 | P24 | 72 | hr | 1389 | 2744 | 5667 | 0.4841 | 0.3167 |
SK-BR-3 | Trametinib | 0.04 | uM | LJP5 | 1 | P24 | 72 | hr | 2543 | 3405 | 5578 | 0.6104 | 0.2839 |
MDA-MB-231 | Trametinib | 0.04 | uM | LJP5 | 3 | P24 | 72 | hr | 1311 | 1672 | 5013 | 0.3335 | 0.0973 |